182 related articles for article (PubMed ID: 36499174)
1. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
[TBL] [Abstract][Full Text] [Related]
2. Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro.
Li Y; Wei Y; Li G; Huang S; Xu J; Ding Q; Hong J
Transl Vis Sci Technol; 2022 Feb; 11(2):8. PubMed ID: 35119473
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
[TBL] [Abstract][Full Text] [Related]
4. [A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture].
Karpov DS; Karpov VL; Klimova RR; Demidova NA; Kushch AA
Mol Biol (Mosk); 2019; 53(1):91-100. PubMed ID: 30895956
[TBL] [Abstract][Full Text] [Related]
5. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
[TBL] [Abstract][Full Text] [Related]
6. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
Elife; 2019 Dec; 8():. PubMed ID: 31789594
[TBL] [Abstract][Full Text] [Related]
7. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
Zhang I; Hsiao Z; Liu F
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
[TBL] [Abstract][Full Text] [Related]
8. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
Chen YC; Sheng J; Trang P; Liu F
Viruses; 2018 May; 10(6):. PubMed ID: 29844277
[TBL] [Abstract][Full Text] [Related]
9. Construction and Optimization of Herpes Simplex Virus Vectors for Central Nervous System Gene Delivery based on CRISPR/Cas9-mediated Genome Editing.
Huang X; Li X; Yang L; Wang P; Yan J; Nie Z; Gao Y; Li Z; Wen J; Cao X
Curr Gene Ther; 2022; 22(1):66-77. PubMed ID: 34148538
[TBL] [Abstract][Full Text] [Related]
10. Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions.
Xu H; Wang J; Deng Y; Hou F; Fu Y; Chen S; Zou W; Pan D; Chen B
J Virol; 2022 Dec; 96(24):e0092022. PubMed ID: 36453882
[TBL] [Abstract][Full Text] [Related]
11. Generation and validation of recombinant herpes simplex type 1 viruses (HSV-1) using CRISPR/Cas9 genetic disruption.
Bommareddy PK; Peters C; Kaufman HL
Methods Enzymol; 2020; 635():167-184. PubMed ID: 32122544
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 Mutagenesis of UL21 in Multiple Strains of Herpes Simplex Virus Reveals Differential Requirements for pUL21 in Viral Replication.
Finnen RL; Banfield BW
Viruses; 2018 May; 10(5):. PubMed ID: 29762484
[TBL] [Abstract][Full Text] [Related]
13. Gene editing and elimination of latent herpes simplex virus in vivo.
Aubert M; Strongin DE; Roychoudhury P; Loprieno MA; Haick AK; Klouser LM; Stensland L; Huang ML; Makhsous N; Tait A; De Silva Feelixge HS; Galetto R; Duchateau P; Greninger AL; Stone D; Jerome KR
Nat Commun; 2020 Aug; 11(1):4148. PubMed ID: 32811834
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Based Genome Editing of HSV.
Velusamy T; Gowripalan A; Tscharke DC
Methods Mol Biol; 2020; 2060():169-183. PubMed ID: 31617178
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro.
Vasques Raposo J; Rodrigues Carvalho Barros L; Ribas Torres L; Barbosa da Silva Pinto R; De Oliveira Lopes A; Mello de Souza E; Hernan Bonamino M; Salete de Paula V
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):19-23. PubMed ID: 37715442
[TBL] [Abstract][Full Text] [Related]
16. Developing oncolytic
Ebrahimi S; Makvandi M; Abbasi S; Azadmanesh K; Teimoori A
Iran J Basic Med Sci; 2020 Jul; 23(7):937-944. PubMed ID: 32774817
[TBL] [Abstract][Full Text] [Related]
17. Screening Method for CRISPR/Cas9 Inhibition of a Human DNA Virus: Herpes Simplex Virus.
Neuhausser WM; Oh HS; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
Bio Protoc; 2020 Sep; 10(17):e3748. PubMed ID: 33659408
[TBL] [Abstract][Full Text] [Related]
18. [Antiviral activity of the organic germanium complex with aciclovir against herpes simplex virus (Herpesviridae: Alphaherpesvirinae: Simplexvirus: Human alphaherpesvirus 1/2) in the in vitro and in vivo systems].
Alimbarova LM; Ambrosov IV; Matelo SK; Barinsky IF
Vopr Virusol; 2021 Nov; 66(5):368-382. PubMed ID: 34738452
[TBL] [Abstract][Full Text] [Related]
19. Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice.
Yin D; Ling S; Wang D; Dai Y; Jiang H; Zhou X; Paludan SR; Hong J; Cai Y
Nat Biotechnol; 2021 May; 39(5):567-577. PubMed ID: 33432198
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of
Gao J; Yan X; Banfield BW
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
